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Summary: A differential immunoturbidimetric procedure for the quantitation of apolipoprotein A-I associated
with lipoproteins LpA (containing both apolipoprotein A-I and apolipoprotein A-II) and with lipoproteins
LpA-I (containing apolipoprotein A-I but no apolipoprotein A-II) is presented. Lipoproteins containing
apolipoprotein A-II are precipitated with an anti-apolipoprotein A-II antibody. The resulting immunoprecip-
itate is sedimented and LpA-IA_i is measured in the supernate. Whereas LpA-IA_! concentrations differed
significantly between normolipidaemic men and women (0.75 and \ .00 g/1, respectively), there was virtually
no sex related difference in LpAA_i (0.83 and 0.88 g/1, respectively). LpA-IA.i was predominantly correlated
with HDL2-cholesterol (rs = 0.630), whereas LpAA.r was statistically associated with HDL3 (rs = 0.417).
Introduction
Plasma HDL1) are involved in cholesterol esterifica-
tion and transport. Clinical and epidemiological data
suggest an inverse relationship between HDL concen-
tration and cardiovascular risk (1). HDL do not con-
sist of an homogeneous molecular species, but re-
present a complex mixture of lipoprotein particles
differing in physicpchemical characteristics such as
hydrated density, particle size, lipid and apolipopro-
tein composition (2).
Apolipoprotein A4 and apolipoprotein A-II are the
major HDL apolippproteins. Together they constitute
approximately 90% of the protein associated with
HDL. In normolipidaemic human plasma more than
!) Abbreviations: VLDL, LDL, HDL: very low, low, and high
density lipoproteins; LpA, lipoproteins with apolipoprotein
A-I and apolipoprotein A-II; LpA-I, lipoproteins with
apolipoprotera A-I but no apolipoprotein A-II; LpAA.b
LpA*IA-i, apolipoprotein A-I associated with LpA and LpA-
I, respectively; EDTA, ethylenediaminetetraacetate; TRIS,
tris(hydroxymethyl)aminomethane; ELISA, enzyme-linked
immunosorbent assay.
90% of apolipoprotein A-I and 95% of apolipopro-
tein A-II are found within the HDL density range.
Both apolipoproteins modulate lecithin cholesterol
acyltransferase (EC 2.3.1.43) activity (3) and appear
to be ligands for HDL receptors (4). Apolipoprotein
A-II is an activator of hepatic triacylglycerol lipase
(EC 3.1.1.34) (5).
At least two forms of apolipoprotein A containing
lipoproteins can be distinguished: particles with both
apolipoprotein A-I and apolipoprotein A-II (= LpA),
and particles with apolipoprotein A-I but no apoli-
poprotein A-II (= LpA-I) (6 — 9). Recent observa-
tions suggest that LpA-I, but not LpA, promote cho-
lesterol efflux from cultured adipose cells (10).
Differential quantitation of the two particle species
has been accomplished by 'tandem gel' electroimmu-
noassay (11, 12), differential antibody ELISA (13)
and radioimmunoassay following immunoprecipita-
tion (14). Herein we report the development of a
simple immunoturbidimetric procedure for the quan-
tification of the two particle species in terms of their
apolipoprotein A-I moiety (LpAA.i and LpA-IA-i).
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Materials and Methods
Plasma samples
Blood samples were obtained from healthy donors after an
overnight fast and drawn into tubes containing EDTA · K2
(final concentration 1.5-2 g/1). Plasma was recovered by low
speed centrifugation (1500g, 30 min).
Preparat ion of LpA-I
HDL were isolated from pooled human serum (supplemented
with 0.4 g/1 EDTA · Na2 and 0.5 g/1 NaN3) by sequential
preparative ultracentrifugation in a KONTRON type TFT
50.38 rotor within the density range of 1.063 kg/1 (44000 min-1,
2.6 · 10s £ · min) and 1.21 kg/1 (44000 min-1, 3.4 · 108g · min).
Densities were adjusted with solid NaBr and monitored with a
DMA 55 digital precision density meter (A. Paar, Graz, Au-
stria). HDL were washed by recentrifugation at d = 1.21 kg/1
and then subfractionated by chromatofocusing as described by
Nestruck et al. (15). In brief, HDL (25 — 35 mg protein) were
dialysed against the chromatofocusing starting buffer (pipera-
zine-HCl, pH 5.8), applied to a column (bed height 38 cm,
diameter 1 cm) with Polybuffer Exchanger (Pharmacia Fine
Chemicals, Uppsala, Sweden) and eluted with Polybuffer 74
(diluted 1:15 with bidistilled water, pH 4.0) at a flow rate of
22 ml/h. Additional chromatofocusing experiments were carried
out with 250 ml/1 glycerol present in all solutions.
'Tandem gel' e lectroimmunoassay for LpA-IA_j
An electroimmunoassay plate was subdivided into anti-apoli-
poprotein A-II and anti-apolipoprotein A-I containing sections.
During sample migration, lipoproteins containing apolipopro-
tein A-II were retained in the anti-apolipoprotein A-II contain-
ing section, whereas LpA-I reached the attached gel with anti-
apolipoprotein A-I (11, 12).
Our electrophoresis buffer contained 25 mmol/1 barbital, 70
mmol/1 TRIS-HC1, pH 8.8, 107 mg calcium lactate, and 130
mg/1 NaN3. The gel consisted of 10 g/1 agarose (Seakem LE,
-mr = 0.10-0.15), and 20 g/l dextran T70 (Pharmacia). Rabbit
anti-apolipoprotein A-II (35 ml/l) (Immuno AG, Vienna, Au-
stria) or rabbit anti-apolipoprotein A-I (40 ml/1) (Immuno)
were added to the gel solution. The sample volume was 5 μΐ.
Electrophoresis was performed at a constant current of 20 mA
and 15 °C for 5 h. Staining with Coomassie Brilliant Blue was
performed as described (16), and rocket lengths were deter-
mined in tenths of a millimeter with a viewer for immunoana-
lysis (Behringwerke, Marburg, FRG).
Non-compet i t ive ELISA for apolipoprotein A-II
Microtitre plates (Nunc Immuno Plate I) were coated overnight
with 0.1 ml anti-apolipoprotein Α-ΙΙ-γ-globulin (from sheep,
Boehringer Mannheim) diluted 1:500 (corresponding to a final
concentration of around 7 mg/1 specific anti-apolipoprotein
A-II) in 0.2 mol/1 carbonate buffer, pH 10.0, blocked in 10 g/1
gelatine (in coating buffer), and washed with 0.2 ml phosphate
buffered saline containing 0.5 ml/1 Tween 20. Samples (0.1 ml)
were incubated for 4 h and the solid phase was subsequently
blocked, washed twice, and incubated l h with 0.1 ml 1:500
diluted anti-apolipoprotein A-II (from rabbit, Immuno). After
three additional washes the wells were incubated for l h with
0:1 ml 1:500 diluted horseradish peroxidase conjugated to anti-
rabbit-IgG (from goat, Biorad Laboratories, Munich, FRG).
Colour was developed with an -phenylene diamine (OPD)
reagent (Abott Diagnostic Products, Wiesbaden, FRG). The
reaction was stopped by addition of 0.5 mol/1 H2SO4 and
absorbances were read at 450 nm (titertek MCC 340, Flow
Laboratories).
Differential turbidimetric measurement of LpAA.f
and LpA-IA-i
Lipoproteins containing apolipoprotein Α-ΙΪ were immunopre-
cipitated with an antibody specific for apolipoprotein Α-ΪΙ.
Subsequently, immune complexes were sedimented by centri-
fugation and LpA-IA_i was determined, in an aliquot of the
supernate.
In detail: Plasma was diluted 20-fold with 10 minol/1 potassium
phosphate, pH 7.4, 0.15 mol/1 NaCl. Sheep polyclonal anti-
apolipoprotein A^II (γ-globulin fraction, 3.5 g specific antibody
per litre, Boehringer Mannheim) was diluted tenfold with the
same buffer additionally containing 40 g/l polyethylene glycol
(Mr 6000, Serva Heidelberg, FRG). In addition, 10-, 15-, 20-,
30-, and 40-fold dilutions of the secondary standard serum,
sample blanks (1.0 ml phosphate/NaCl with polyethylene glycol
plus 50 μΐ of the diluted sample) and a reagent blank were
prepared. Diluted sample or standard (50 μΐ) was mixed with
1 ml of the diluted antibodies. After incubation for 21A h at
20—25 °C, the mixture was swirled and absorbances read at
365 nm: sample against reagent blank and sample blank against
phosphate buffer with polyethylene glycol. This step provided
a value for the total apolipoprotein Α-ΙΪ concentration. The
immunoprecipitate was then sedimented by centrifugation at
2000 g for 20 min, and 0.9 ml of the supernate was transferred
to fresh tubes (It has been confirmed by absorbance measure-
ments of the supernate that the immunoprecipitate is completely
removed under these conditions). 0.1 ml undiluted polyclonal
anti-apolipoprotein A-I (γ-globulin fraction from sheep, 5.2 g
specific antibody per litre, Boehringer Mannheim) was added,
incubated for 21A h, and the absorbance measurements were
repeated. Finally, LpA-IA.i was determined by reference to the
calibration curve, and LpAA_i was calculated as the difference
between total apolipoprotein A-I (measured with the sheep anti-
apolipoprotein A-I from Boehringer Mannheim according to
the supplier's instructions) and LpA-IA.r.
Standardization
Two approaches were pursued to quantify LpAA_! and LpA-IA_i
in a deep-frozen reference pool of human plasma, which then
served as a secondary calibrator for the differential turbidi-
metric assay:
a) LpA-I isolated by chromatofocusing was used as a standard
in a 'tandem gel' electroimmunoassay for LpA-IA.|. Apoli-
poprotein A-I had been measured in this preparation by
zone immunoelectrophoresis (16, 17) in reference to a lyo-
philized commercial standard serum (Reference Standard
for human apolipoproteins, Immuno AG, apolipoprotein
A-I: 0.825 g/1).
b) LpA-I was measured in terms of its apolipopfotein A-I
content in the supernate after precipitation of LpA with
anti-apolipoprotein A-II. Here again a commercial reference
serum (Apolipoprotein Standard Boehringer Mannheim,
apolipoprotein A-I: 1.45 g/1) served as the standard.
Miscellaneous analytical methods
Zone immunoelectrophoresis (16, 17) and discontinuous poly-
acrylamide gel electrophoresis (T = 12.5%, C = 2.7%) in the
presence of SDS (18) were performed as described. Cholesterol,
triacylglycerols and phospholipids were measured enzymatically
using commercial reagents (Boehringer Mannheim). VLDL-
cholesterol and HDL-cholesterol were determined with a com-
bined centrifugation/precipitation method (19). HDL2 and
HDL3 were separated by ultracentrifugation at d = 1.125 kg/1
in the supernate after precipitation (phosphotungstate/MgCl2)
of apolipoprotein B-containing lipoproteins (20).
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Statistics
The statistical analysis (rank sum test of Mann, Whitney, and
Wilcoxon, Spearman's rank correlation) was carried out with
the SPSSX batch system (release 2.0 on Sperry 1100).
Results
Preparation of LpA-I
A representative protein profile obtained by chro-
matofocusing of HDL is shown in figure la. Frac-
tionation of the same sample in the presence of glyc-
erol but under otherwise identical conditions appar-
ently diminishes the heterogeneity of the elution pat-
tern (fig. Ib). Since glycerol stabilizes proteins at their
isoelectric point this possibly indicates that in the
absence of glycerol artificial polymorphism may have
been generated.
On SDS-PAGE and 'tandem gel' immunoelectropho-
resis (fig. 2) the shaded fraction in the elution curve
of figure Ib contained apolipoprotein A-I but no
apolipoprotein A-II. It was therefore considered to




















Fig. 1. Preparation of LpA-I by chromatofocusing (see text for
experimental conditions) a) in the absence of glycerol
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Fig. 2. a) Calibration of a secondary standard for the deter-
mination of LpA-IA-i by *tandem gel' electroimmunoas-
say. Anti-human-apolipoprotein A-II was added to the
lower, anti-apolipoprotein A-I to the upper gel section.
Wells 1—6 contained three different amounts of purified
LpA-I (in duplicate); 1:50 and 1:80 dilutions of the
secondary standard were run in wells 7—10.
b) Standard curve. Each point represents the mean
precipitate length of the respective LpA-I dilution (wells
1-6 in a).
Differential immuno turbidimetric determi-
nation of LpAA-i and LpA-IA-i
On analysis in the 'tandem gel' electroimmunoassay
the reference serum contained 0.590 g/1 apolipopro-
tein A-I associated with LpA-I. As quantified by zone
immunoelectrophoresis its total apolipoprotein A-I
concentration was 1.332 g/1. The turbidimetric assess-
ments gave values of 0.599 g/1 LpA-IA-i and 1.322 g/1
total apolipoprotein A-I. The two standardization
procedures therefore closely agree with each other.
Siipernates (0.1 ml aliquots) after the precipitation of
LpA were checked for the presence of residual apo-
lipoprotein A-II by means of zone immunoelectro-
phoresis and a sensitive ELISA (detects down to 2 ng
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apolipoprotein A-II) without further dilution. Irre-
spective whether the initial precipitation of apolipo-
protein A-II containing lipoproteins was conducted
in 10-, 15-, 20-, 30-, or 40-fold dilutions of the sam-
ples, absorbance readings in the enzyme immunoassay
did not significantly exceed blank values. Consist-
ently, on zone immunoelectrophoresis, neither super-
nate contained apolipoprotein A-II (cf. fig. 3). This
indicates that apolipoprotein A-II containing lipopro-
teins are virtually completely removed by the immu-
noprecipitation step throughout the concentration
range covered by the turbidimetric assay.
Calibration curves for the estimation of LpA-IA-i,
total apolipoprotein A-I and apolipoprotein A-II con-
structed from dilutions of the reference serum are
shown in figure 4. Within a broad measuring range
there are linear responses to the amounts of either
antigen. The standard curves for apolipoprotein A-I
in either LpA-I or whole plasma coincide, suggesting
that the immiinoreaction is insensitive to the nature
of the apolipoprotein A-I containing particle.
13 17
0.4 0.8 1.2 1J6 2JO 2A
Amount of antigen 1/ig]
Fig. 3. Zone immunoelectrophoresis assay for apolipoprotein
A-II in the supernate after immunoprecipitation of li-
poproteins containing apolipoprotein A-II. The gel con-
tained 8 ml/1 anti-apolipoprotein A-II γ-globulin frac-
tion (from sheep, Boehringer Mannheim). In corre-
spondence with the standard curve of the differential
turbidimetric assay, aliquots of a single plasma sample
were diluted 10-, 15-, 20-, 30-, and 40-fold with 10
mmol/1 potassium phosphate, pH 7.4, 0.15 mol/1 NaCl.
These samples were then further diluted 20-fold in order
to account for the dilution introduced by the immu-
noprecipitation step and 20 μΐ were loaded to rods 1, 5,
9, 13, and 17. Rods 2, 6, 10, 14, and 18 contain 40 'μΐ'
rods 3, 7, 11, 15, and 19 contain 20 μΐ of the respective
supernates after immunoprecipitation, and twofold di-
lutions of these supernates were applied to rods 4, 8,
12, 15, and 20. After immunoprecipitation apolipopro-
tein A-II is absent from the supernates.
Fig. 4- Calibration curves for the turbidimetric determinations
of apolipoprotein A-I (x), apolippprotein A-II (·), and
LpA-U.! (O). Each data point represents the mean of
duplicate measurements (experimental details are de-
scribed in the text).
In normolipidaemic samples, reagent blanks were al-
ways within 0.02 absorbance units. Some hypertri-
glyceridaerriic sera, however, gave higher values, rang-
ing from 0.03 to 0.06. In order to exclude the possi-
bility that net absorbance readings were substantially
influenced by triacylglycerol-rich lipoproteins, we en-
riched a normolipidaemic plasma with highly concen-
trated VLDL prepared from a plasma pool of nor-
molipidaemic donors. Within the range of 1.14 mmol/1
to 3.2 mmol/1 triacylglycerols absorbances remained
unaffected although the sample blanks increased from
0.006 to 0.022.
The within batch coefficient of variation was 4.4%
(n = 10) for the determination of LpA-I/^. Its be-
tween batch coefficient of variation was 8.6% as
estimated by analyses of a deep frozen (-25°C)
plasma sample (mean LpA-IA_! = 0.62 g/1) on η = 8
working days.
LpAA_! and LpA-IA.j in human plasma
Along with lipoprotein and apolipoprotein concen-
trations, LpAA_! and LpA-IA.r were determined in
η = 28 (15 male and 13 female) healthy Volunteers
(age 26 ±6 years). Results are compiled in table 1.
Apolipoprotein A-II and LpAA.x concentrations did
not differ significantly between the sexes, but total
apolipoprotein A-I was significantly higher in males
than in females, and the difference evidently origi-
nated in changes of LpA-I rather than of LpA.
Correlations between LpA-IA,r, LpAA_l5 apolipopro-
tein and lipoprotein concentrations are compiled in
table 2. As would tje anticipated, there were good
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Tab. 1. Mean values (medians in parenthesis) for apolipopro-




































































Differences between males and females: * p < 0.05, ** p < 0.01
(rank sum test of Mann, Whitney, and Wilcoxori)
Tab. 2. Correlations between LpA-IA.i, LpAA_i, apolipoproteins
and lipoproteins (Spearman's rank correlation coeffi-













































p < 0.05, ** p < 0.01
correlations between apolipoprotein A-I and HDL-
cholesterol, HDL2-cholesterol, and HDL3-cholesterol.
Apolipoprotein A-II, in contrast, was significantly
associated only with HDL3-cholesterol, and not with
HDL-cholesterol or HDl^-cholesterol. Intriguingly,
LpA-I was more closely correlated with HDL2 than
with HDL3, and LpAAj was more strongly correlated
with HDL3 than with HDL2.
Discussion
The turbidimetric procedure for the differential de-
termination of LpA-IA-i and LpAA-i is rapid and sim-
ple. As has been verified by an ELISA technique and
zone immunoelectrophoresis, the immunoprecipita-
tion with anti-apolipoprotein A-II affords complete
removal of apolipoprotein A-II containing particles.
Thus the subsequent assay for LpA-I^j is specific.
Two strategies for its standardization arrived at vir-
tually identical results. This suggests that the proce-
dure has been calibrated accurately, and that, in rou-
tine practice, the turbidimetric determination of apo-
lipoprotein A-I in the supernate after precipitation of
LpA will permit convenient yet accurate standardiza-
tion. Hence, the differential method is readily avail-
able to any laboratory already running turbidimetric
determinations of apolipoprotein A-I and apolipo-
protein A-II.
Although in general the incorporation of detergents
into turbidimetric assays eliminates background tur-
bidity, they were omitted here in order to preserve the
original lipoprotein structure. A sample blank should
therefore be run in parallel in particular for hyper-
triglyceridaemic sera.
Hitherto, differential quantitation of LpA and LpA-I
have been carried out by 'tandem gel' (i. e. double gel)
electroimmunoassay (11, 12), ELISA (13) or by ra-
dioimmunoassay after precipitation of LpA (14). This
is the first report on a turbidimetric assay for the two
particle species. Compared with the other techniques
it has several advantages: it is less tedious, does not
demand specific equipment and may partially be au-
tomated. Drawbacks are antibody consumption and
comparatively lower sensitivity which, however, is
perfectly adequate for determination of plasma con-
centrations encountered in practice, and the method
incidentally avoids large-scale dilution as a source of
analytical error.
Differential measurement of LpA and LpA-I allows
the straightforward classification of variations in the
plasma apolipoprotein A-I/A-II ratio which, in prin-
ciple, may be brought about by either changes in the
composition of the apolipoprotein -containing li-
poproteins or by variations in the relative proportions
of their subspecies.
Our reference values for LpA-I and LpA were estab-
lished in a limited population sample and may there-
fore be considered as preliminary. Nevertheless, they
are in fair accordance with data obtained with 'tan-
dem gel' electroimmunoassay (11) and differential
antibody ELISA (13), and, in keeping with the latter
study, they suggest that the well documented sex
difference in apolipoprotein A-I is attributable to
LpA-I rather than to LpA.
The present work also provided statistical evidence
that LpA-I is associated to some extent with HDL2,
which is concurrently regarded the major anti-athero-
genic HDL-subfraction. This may be related to the
observation that within HDL2 roughly two thirds of
apolipoprotein A-I reside on the LpA-I subspecies
(13).
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In conclusion, our method provides an efficient tool
for the quantitative differentiation of LpA and LpA-J.
Further clinical and experimental research is now
required to gain insights into the physiological and
diagnostic significance of the two particle subpopu-
lations.
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